News
With tremendous social and economic costs, dementia is now the seventh leading cause of death globally, affecting 57 million ...
Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter Provided by PR Newswire Jun 17, 2025, 5:03:00 AM ...
Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of highly selective antibodies for the glucose ...
This is a useful study in the role of CHI3L1 in Kupffer cells, the macrophages of the liver, showing that CHI3L1 alters glucose regulation in obesity. Specifically, Chi3l1 protects glucose-dependent ...
PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of ...
Professor Sun Jinpeng's team and Professor Yu Xiao's team at Shandong University, collaborating with Professor Jiang Changtao from Peking University, Professor ...
The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...
8d
Zacks Investment Research on MSNShould You Continue to Retain Abbott Stock in Your Portfolio Now?Abbott ABT is witnessing increased global demand for routine diagnostic tests over the past few quarters. The Diabetes Care business continued to benefit from the growing sales of its flagship, sensor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results